Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Moore

Showing results (211-220 of 320) with videos related to

Pageof 32
Sort By:
AIDS Research and Human Retroviruses|July 3, 2007
Purified, proteolytically mature HIV type 1 SOSIP gp140 envelope trimersSai Prasad N Iyer, Michael Franti, Ammie A Krauchuk, et al.
Journal of Virology|April 15, 2003
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entryFotini Tsamis, Svetlana Gavrilov, Francis Kajumo, et al.
Journal of Virology|March 3, 2004
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitorShawn E Kuhmann, Pavel Pugach, Kevin J Kunstman, et al.
Plos Pathogens|October 30, 2023
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralizationRajesh P Ringe, Philippe Colin, Gabriel Ozorowski, et al.
Virology|November 28, 2006
A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120Simon Beddows, Michael Franti, Antu K Dey, et al.
Virology|February 24, 2006
Interaction of small molecule inhibitors of HIV-1 entry with CCR5Christoph Seibert, Weiwen Ying, Svetlana Gavrilov, et al.
The Journal of Biological Chemistry|February 8, 2019
Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimersSteven W de Taeye, Eden P Go, Kwinten Sliepen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2011
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maravirocClaire J Forbes, Deborah Lowry, Leslie Geer, et al.
Journal of Virology|December 30, 2011
Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responsesMark Melchers, Ilja Bontjer, Tommy Tong, et al.
Cell Reports|June 9, 2015
Structural Constraints Determine the Glycosylation of HIV-1 Envelope TrimersLaura K Pritchard, Snezana Vasiljevic, Gabriel Ozorowski, et al.
Pageof 32

Showing results (211-220 of 320) with videos related to

Sort By:
Pageof 32
AIDS Research and Human Retroviruses|July 3, 2007
Purified, proteolytically mature HIV type 1 SOSIP gp140 envelope trimersSai Prasad N Iyer, Michael Franti, Ammie A Krauchuk, et al.
Journal of Virology|April 15, 2003
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entryFotini Tsamis, Svetlana Gavrilov, Francis Kajumo, et al.
Journal of Virology|March 3, 2004
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitorShawn E Kuhmann, Pavel Pugach, Kevin J Kunstman, et al.
Plos Pathogens|October 30, 2023
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralizationRajesh P Ringe, Philippe Colin, Gabriel Ozorowski, et al.
Virology|November 28, 2006
A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120Simon Beddows, Michael Franti, Antu K Dey, et al.
Virology|February 24, 2006
Interaction of small molecule inhibitors of HIV-1 entry with CCR5Christoph Seibert, Weiwen Ying, Svetlana Gavrilov, et al.
The Journal of Biological Chemistry|February 8, 2019
Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimersSteven W de Taeye, Eden P Go, Kwinten Sliepen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2011
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maravirocClaire J Forbes, Deborah Lowry, Leslie Geer, et al.
Journal of Virology|December 30, 2011
Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responsesMark Melchers, Ilja Bontjer, Tommy Tong, et al.
Cell Reports|June 9, 2015
Structural Constraints Determine the Glycosylation of HIV-1 Envelope TrimersLaura K Pritchard, Snezana Vasiljevic, Gabriel Ozorowski, et al.
Pageof 32